Cancer Research
1 view | +0 today
Follow
Your new post is loading...
Your new post is loading...
Scooped by Dr. Michael Wosnick
Scoop.it!

Rise in thyroid cancer diagnoses challenged by Mayo researchers - Minneapolis Star Tribune

Rise in thyroid cancer diagnoses challenged by Mayo researchers - Minneapolis Star Tribune | Cancer Research | Scoop.it
Minneapolis Star Tribune
Rise in thyroid cancer diagnoses challenged by Mayo researchers
Minneapolis Star Tribune
New approach for small thyroid lesions could shield patients from unnecessary risks and costs of cancer treatment.
more...
No comment yet.
Rescooped by Dr. Michael Wosnick from Breast Cancer News
Scoop.it!

Why aren't there more cancer vaccines?

Why aren't there more cancer vaccines? | Cancer Research | Scoop.it

"Six years from now, when my daughter turns 11, she will get a three-part human papillomavirus vaccine that will reduce her chances of getting cervical cancer by about 70 percent. Currently a little over half of American girls get the HPV vaccine, a public health intervention that will prevent tens of thousands of cancers. It's one of modern medicine's few success stories in finding a means of preventing cancer.

Maybe the reason we have so few cancer vaccines is that they're harder to develop than treatments for patients who already have cancer, which are more common. But in an as yet unpublished study, economists Eric Budish and Heidi Williams teamed up with patent lawyer Ben Roin to argue that the scarcity of preventive measures and relative abundance of late stage cancer treatments can also be blamed on the distorting effects that the U.S. patent system has on medical research."


Via Susan Zager
Dr. Michael Wosnick's insight:

The good news is that longer and longer survival times are what we aim for. The bad news is that long lead times and long followup times for testing vaccines makes it difficult for companies to enter the fray since they can't get patent protection for long enough to protect their investment.

more...
Susan Zager's curator insight, August 27, 2013 5:52 PM

This article takes a great in depth look at why there aren't more cancer vaccines in the US. It takes into account the problems with our patent system and other regulations which add to the reasons that medical research isn't making cancer vaccines a priority.

It is fortunate that the NBCC sees a vaccine to prevent breast cancer as a priority. For more information about @deadline2020 go to: http://www.breastcancerdeadline2020.org/about-the-deadline/